Significance, Assessment and Treatment of Head and Neck Lymphedema
Dr. Bhayani shares best practices for identifying and treating patients with head and neck lymphedema (HNL) using case studies and recent clinical data:
- With the growing number of cancer survivors, pre-habilitation and rehabilitation are increasingly important in cancer care.
- Up to 90% of head and neck cancer survivors suffer from HNL.
- Flexitouch® Plus pneumatic compression device is clinically proven to improve patients HNL symptoms.1
1Ridner, S.H. et al. Support Care Cancer (2020)
Click the timestamps below to jump to video segments on YouTube:
2:35 Trends in HN Cancer: the importance of HPV
9:39 The biggest risks in HNC cancer survivorship
14:35 Lymphedema – prevalence and presentation
16:33 New clinical data: Internal lymphedema persists in the long term
20:18 Diagnosing lymphedema through imaging
22:47 Treating HN lymphedema and introduction to Flexitouch
25:26 Clinical evidence of Flexitouch improvements
30:40 Real life evidence of Flexitouch improvements
34:00 The correlation between external and internal lymphedema?
35:35 In Summary – We need to focus on survivorship
37:23 Barriers to treating lymphedema
39:58 Cancer care team treating lymphedema
42:02 Introduction to Patient Gail
44:25 Patient Gail’s testimonial
49:24 Q&A Session: When do you diagnose lymphedema? Send to therapy? Refer Flexitouch?